Texas · 86340

Intrinsic Factor (stomach Protein) Antibody Measurement in Texas

Texas Medicare Avg
$14.78
0% above national avg
National Medicare Avg
$14.75
All states combined
Billed Charge (TX)
$99.52
What providers submit
Est. Commercial (TX)
$33.99
National avg: $33.04
Est. Cash / Self-Pay (TX)
$38.45
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

1.0K
Services in TX
15
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Texas

Provider Medicare Services
Ayass Lung Clinic, Pllc $14.78 264
Quest Diagnostics Clinical... $14.78 169
Quest Diagnostics Clinical... $14.78 162
Clinical Pathology Laboratories,... $14.78 143
Med Fusion, Llc $14.78 128
Laboratory Corporation Of America $14.78 99
Laboratory Corporation Of America $14.78 57

Texas Pricing in Context

In Texas, CPT code 86340 (Intrinsic Factor (stomach Protein) Antibody Measurement) carries an average Medicare payment of $14.78 — 0% above the national benchmark of $14.75. 15 providers across the state submitted claims for this procedure in 2023, performing 1.0K total services. Individual payments in TX ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Texas is $99.52, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Texas sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Immunology procedures, the estimated commercial insurance price in Texas lands near $33.99, with self-pay cash prices typically around $38.45. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Intrinsic Factor (stomach Protein) Antibody Measurement cost in Texas?

The average Medicare payment for Intrinsic Factor (stomach Protein) Antibody Measurement in Texas is $14.78, which is 0% above the national average of $14.75. Providers in TX typically bill $99.52 for this procedure.

What does Intrinsic Factor (stomach Protein) Antibody Measurement cost with insurance in Texas?

With commercial insurance in Texas, Intrinsic Factor (stomach Protein) Antibody Measurement costs an estimated $33.99. Without insurance, the estimated cash price is $38.45. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Intrinsic Factor (stomach Protein) Antibody Measurement in Texas?

15 providers in Texas billed Medicare for Intrinsic Factor (stomach Protein) Antibody Measurement in 2023, performing 1.0K total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Intrinsic Factor (stomach Protein) Antibody Measurement cheaper in Texas than the national average?

No — Intrinsic Factor (stomach Protein) Antibody Measurement costs 0% above the national average in Texas. The state average Medicare payment is $14.78 compared to $14.75 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial